The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Oncol.
Sec. Gynecological Oncology
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1498631
High-intensity focused ultrasound (HIFU) assisted by a rectal Foley catheter for the treatment of recurrent mucinous ovarian cancer: a case report and literature review
Provisionally accepted- Chongqing Medical University, Chongqing, China
Mucinous ovarian cancer (MOC) is characterized by high malignancy, poor prognosis and a high recurrence rate. Surgical adjuvant chemotherapy is the main treatment for MOC. The recurrence rate of advanced mucinous ovarian cancer following surgery is significantly high, with limited efficacious treatment options available. Moreover, chemotherapy alone results in low sensitivity in this context. High-intensity focused ultrasound (HIFU) not only efficiently ablates targeted tumor lesions but also elicits an immune response within the body and increases tumor cell susceptibility to drugs, thus increasing therapeutic effectiveness. We report a case of recurrent mucinous ovarian cancer treated with HIFU combined with chemotherapy, which effectively controlled tumor growth and prolonged patient survival. High-intensity focused ultrasound in combination with chemotherapy for the treatment of recurrent and surgically difficult ovarian cancer could provide new treatment strategies.
Keywords: High-intensity focused ultrasound, mucinous ovarian cancer, tumor recurrence, chemotherapy, combined therapy
Received: 22 Sep 2024; Accepted: 19 Nov 2024.
Copyright: © 2024 Guo, Liu, Zhou, Zhu, Pan, Feng and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Wei Liu, Chongqing Medical University, Chongqing, China
Kun Zhou, Chongqing Medical University, Chongqing, China
Hui Zhu, Chongqing Medical University, Chongqing, China
Lu Pan, Chongqing Medical University, Chongqing, China
Chunping Feng, Chongqing Medical University, Chongqing, China
Ling Liu, Chongqing Medical University, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.